This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

ReNeuron Group Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	no data
Proprietà del CEO	n/a
Durata media del management	1.7yrs
Durata media del Consiglio di amministrazione	1.7yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

ReNeuron Group non ha un CEO, o non abbiamo dati su di loro.

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Iain Ross	Executive Chairman	2.8yrs	UK£430.00k	0.70% € 15.7k
John Hawkins	Company Secretary	2.9yrs	UK£192.91k	0.26% € 5.8k
John Sinden	Co-Founder	no data	UK£222.00k	Nessun dato
Suzanne Hancock	Chief Operations Officer	3.8yrs	Nessun dato	0.074% € 1.7k
Randolph Corteling	Chief Scientific Officer	1.7yrs	Nessun dato	Nessun dato
Simon Dew	Chief Business Officer	1.5yrs	Nessun dato	Nessun dato

1.7yrs

Durata media

69yo

Età media

Gestione esperta: Il team dirigenziale di RQE1 non è considerato esperto (durata media 1.7 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Iain Ross	Executive Chairman	2.8yrs	UK£430.00k	0.70% € 15.7k
John Hawkins	Company Secretary	1.7yrs	UK£192.91k	0.26% € 5.8k
Martin Walton	Independent Non-Executive Director	2.2yrs	UK£50.00k	0.026% € 590.2
Barbara Staehelin	Senior Independent Non-Executive Director	2.8yrs	UK£60.00k	0.61% € 13.8k
Michael Owen	Independent Non-Executive Director	8.4yrs	UK£48.00k	0.020% € 447.6
Stefano Pluchino	Chair of the Scientific Advisory Board	1.7yrs	Nessun dato	Nessun dato
Giuseppe Battaglia	Member of Scientific Advisory Board	1.1yrs	Nessun dato	Nessun dato
Edit Buzas	Member of Scientific Advisory Board	1.1yrs	Nessun dato	Nessun dato
Bernd Giebel	Member of Scientific Advisory Board	1.1yrs	Nessun dato	Nessun dato
Kenneth Witwer	Member of Scientific Advisory Board	1.1yrs	Nessun dato	Nessun dato

1.7yrs

Durata media

60yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di RQE1 non è considerato esperto (durata media del mandato 1.7 anni), il che suggerisce un nuovo consiglio.

This company listing is no longer active

ReNeuron Group Gestione

Gestione criteri di controllo 0/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

ReNeuron Group plc Announces Resignation of John Hawkins as Chief Financial Officer, Effect from 7 May 2024

ReNeuron Group plc, Annual General Meeting, Aug 22, 2023

High number of new and inexperienced directors

ReNeuron Group plc Appoints Iain Ross as Executive Chairman

Less than half of directors are independent

Less than half of directors are independent

Recent updates

ReNeuron Group Admission to Trading on AIM to Be Cancelled with Effect from 2 September 2024

ReNeuron Group plc Announces Resignation of John Hawkins as Chief Financial Officer, Effect from 7 May 2024

ReNeuron Group plc Provides Group Earnings Guidance for the Second Half and Full Year 2024

New minor risk - Profitability

ReNeuron Group plc to Report First Half, 2024 Results on Nov 09, 2023

ReNeuron Group plc, Annual General Meeting, Aug 22, 2023

Full year 2023 earnings released: UK£0.095 loss per share (vs UK£0.17 loss in FY 2022)

ReNeuron Group plc to Report Q4, 2023 Results on May 25, 2023

High number of new and inexperienced directors

ReNeuron Group plc Appoints Iain Ross as Executive Chairman

First half 2023 earnings released: UK£0.056 loss per share (vs UK£0.092 loss in 1H 2022)

Less than half of directors are independent

Less than half of directors are independent

ReNeuron Group plc Appoints John Hawkins as Chief Financial Officer

Full year 2022 earnings released: UK£0.17 loss per share (vs UK£0.29 loss in FY 2021)

ReNeuron Group plc, Annual General Meeting, Sep 09, 2022

ReNeuron Group plc, Annual General Meeting, Sep 09, 2022

ReNeuron Group plc Announces Appointment of Catherine Isted as Chief Executive Officer, Effective 1 September 2022

Full year 2022 earnings released: UK£0.17 loss per share (vs UK£0.29 loss in FY 2021)

ReNeuron Group plc to Report Fiscal Year 2022 Results on Jul 04, 2022

ReNeuron Group plc, Annual General Meeting, Jul 14, 2022

ReNeuron Group plc Announces CEO Changes, Effective 28 February 2022

ReNeuron Group plc Announces Leaving of Olav Hellebø as Executive Director

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Board Member recently bought €59k worth of stock

Full year 2021 earnings released: UK£0.29 loss per share (vs UK£0.36 loss in FY 2020)

Full year 2021 earnings released: UK£0.29 loss per share (vs UK£0.36 loss in FY 2020)

ReNeuron Group plc Announces Resignation of Michael Hunt, Chief Financial Officer

New 90-day high: €1.16

New 90-day low: €0.80

First half 2021 earnings released: UK£0.22 loss per share

New 90-day low: €0.85

ReNeuron Group plc to Report First Half, 2021 Results on Nov 10, 2020

New 90-day low - €0.94

ReNeuron Group plc Auditor Raises 'Going Concern' Doubt

Full year earnings released - €0.36 loss per share

New 90-day low - €1.13

New 90-day low - €1.35

AMMINISTRATORE DELEGATO

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media